|
AU2012233008A1
|
|
Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions
|
|
TN2010000490A1
|
|
3,4-substituted piperidine derivatives as renin inhibitors
|
|
WO2011047481A1
|
|
Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2011057382A1
|
|
Spirocyclic piperidine derivatives useful as renin inhibitors
|
|
WO2011020193A1
|
|
Renin inhibitors
|
|
EP2459568A1
|
|
Novel spiro compounds useful as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2010121382A1
|
|
Process for making indole cyclopropyl amide derivatives
|
|
WO2010108268A1
|
|
Heterocyclic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
WO2010069069A1
|
|
Cathepsin b inhibitors
|
|
US2011237622A1
|
|
Renin inhibitors
|
|
AU2009304508A1
|
|
Azetidine derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
|
|
WO2010037225A1
|
|
Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
CA2737483A1
|
|
Indole derivatives as crth2 receptor antagonists
|
|
CA2737460A1
|
|
Indole derivatives as crth2 receptor antagonists
|
|
EP2307334A1
|
|
Synthesis of chiral amines
|
|
CA2724756A1
|
|
3, 4 - substituted piperidine derivatives as renin inhibitors
|
|
AU2009249306A1
|
|
Process for the preparation of an orexin receptor antagonist
|
|
KR20100131007A
|
|
3,4-substituted piperidine derivatives as renin inhibitors
|
|
WO2009129625A1
|
|
Novel substituted heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
|
US2010249192A1
|
|
Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
|
